U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
This repository is under review for potential modification in compliance with Administration directives.

Details

Stereochemistry ABSOLUTE
Molecular Formula C66H103N17O16S
Molecular Weight 1422.697
Optical Activity UNSPECIFIED
Defined Stereocenters 15 / 15
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of BACITRACIN X

SMILES

CC[C@H](C)[C@@H](N)C1=N[C@@H](CS1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H]2CCCCNC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](CC(O)=O)NC(=O)[C@H](CC3=CN=CN3)NC(=O)[C@@H](CC4=CC=CC=C4)NC(=O)[C@@H](NC(=O)[C@@H](CCCN)NC2=O)[C@@H](C)CC

InChI

InChIKey=CLKOFPXJLQSYAH-OKZPNILTSA-N
InChI=1S/C66H103N17O16S/c1-9-35(6)52(69)66-81-48(32-100-66)63(97)76-43(26-34(4)5)59(93)74-42(22-23-50(85)86)58(92)83-53(36(7)10-2)64(98)75-40-20-15-16-25-71-55(89)46(29-49(68)84)78-62(96)47(30-51(87)88)79-61(95)45(28-39-31-70-33-72-39)77-60(94)44(27-38-18-13-12-14-19-38)80-65(99)54(37(8)11-3)82-57(91)41(21-17-24-67)73-56(40)90/h12-14,18-19,31,33-37,40-48,52-54H,9-11,15-17,20-30,32,67,69H2,1-8H3,(H2,68,84)(H,70,72)(H,71,89)(H,73,90)(H,74,93)(H,75,98)(H,76,97)(H,77,94)(H,78,96)(H,79,95)(H,80,99)(H,82,91)(H,83,92)(H,85,86)(H,87,88)/t35-,36-,37-,40-,41+,42+,43-,44+,45-,46-,47+,48-,52+,53-,54-/m0/s1

HIDE SMILES / InChI

Molecular Formula C66H103N17O16S
Molecular Weight 1422.697
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 15 / 15
E/Z Centers 0
Optical Activity UNSPECIFIED

Approval Year

Substance Class Chemical
Created
by admin
on Wed Apr 02 11:12:53 GMT 2025
Edited
by admin
on Wed Apr 02 11:12:53 GMT 2025
Record UNII
FAD7WHW8MC
Record Status FAILED
Record Version
  • Download
Name Type Language
BACITRACIN IMPURITY L [EP IMPURITY]
Preferred Name English
BACITRACIN X
Common Name English
4,10-anhydro[N-[[(4R)-2-[(1R,2S)-1-amino-2-methylbutyl]-4,5-dihydro-1,3-thiazol-4-yl]carbonyl]-L-leucyl-D-?-glutamyl-L-isoleucyl-L-lysyl-D-ornithyl-L-isoleucyl-D-phenylalanyl-L-histidyl-D-?-aspartyl-L-asparagine]
Systematic Name English
Code System Code Type Description
FDA UNII
FAD7WHW8MC
Created by admin on Wed Apr 02 11:12:53 GMT 2025 , Edited by admin on Wed Apr 02 11:12:53 GMT 2025
PRIMARY
Related Record Type Details
PARENT -> IMPURITY
sum of impurities L and N: maximum 8.0 per cent
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP